Malta vs Qatar: Access to anti-retroviral drugs, female
Malta
47.0%
in 2024
Qatar
43.0%
in 2024
Malta rank
124th
Qatar rank
126th
Access to anti-retroviral drugs, female over time
- Malta
- Qatar
How they compare
Malta currently reports 47.0% against 43.0% in Qatar, a difference of 4.0%.
That makes Malta's figure about 1.1 times Qatar's.
The two have swapped places 2 times across 17 shared years of data; in 2000 it was Malta ahead.
Malta ranks 124th and Qatar ranks 126th of 141 countries.
Across the 3 decades both report, Malta averaged higher in 2 and Qatar in 1.
Head to head by decade
| Decade | Malta | Qatar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 22.3% | 0.0% | 22.3% | Malta |
| 2010s | 59.0% | 85.2% | 26.2% | Qatar |
| 2020s | 68.4% | 53.0% | 15.4% | Malta |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Malta or Qatar?
- Malta, at 47.0% against 43.0% in Qatar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Malta and Qatar?
- 4.0%, with Malta ahead.
- How many years of comparable data are there for Malta and Qatar?
- 17 years are reported by both, from 2000 to 2024.
- How do Malta and Qatar rank globally for access to anti-retroviral drugs, female?
- Malta ranks 124th and Qatar ranks 126th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.